Financhill
Buy
55

ANIP Quote, Financials, Valuation and Earnings

Last price:
$82.11
Seasonality move :
9.58%
Day range:
$80.42 - $82.36
52-week range:
$52.74 - $99.50
Dividend yield:
0%
P/E ratio:
50.36x
P/S ratio:
2.01x
P/B ratio:
3.65x
Volume:
516.5K
Avg. volume:
445.3K
1-year change:
51.74%
Market cap:
$1.8B
Revenue:
$614.4M
EPS (TTM):
$1.63

ANIP Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for ANI Pharmaceuticals, Inc. shares anticipate an average target of $109.25, ranging from a low estimate of $90.00 to a high estimate of $121.00. This average target implies a growth of 35.33% compared to the current stock price of $82.11.

Consensus Price Target

$109.25

Highest Price Target

$121.00

Lowest Price Target

$90.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 4 4

Hold 1 1 1

Sell 0 0 0
Consensus Buy Buy Buy

ANIP Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock